Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 USD | +0.08% | -8.16% | -15.89% |
Mar. 21 | Transcript : MiNK Therapeutics, Inc., Q4 2023 Earnings Call, Mar 21, 2024 | |
Mar. 21 | MiNK Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 31.23M |
---|---|---|---|---|---|
Net income 2024 * | -19M | Net income 2025 * | -36M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.75
x | P/E ratio 2025 * |
-1.36
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.67% |
Latest transcript on MiNK Therapeutics, Inc.
1 day | +0.08% | ||
1 week | -8.16% | ||
Current month | -9.09% | ||
1 month | -10.00% | ||
3 months | -1.10% | ||
6 months | -14.29% | ||
Current year | -15.89% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 50 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.9 | +0.08% | 20,100 |
24-05-09 | 0.8993 | -3.30% | 135,759 |
24-05-08 | 0.93 | -0.01% | 18,987 |
24-05-07 | 0.9301 | -1.13% | 58,845 |
24-05-06 | 0.9407 | -4.01% | 119,485 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.89% | 31.23M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- INKT Stock